Lilia Leisle
Associate Research Principal, EVA Market Access
Lilia Leisle is Associate Research Principal, EVA Market Access at Cytel. Lilia’s special interest lies in health equity research promoting new value elements in health technology assessment (HTA) related to gender equity and environmental sustainability. She has co-authored publications covering sex-related health disparities, the impact of climate change on maternal health and newborn outcomes, as well as consideration of health equity and environmental impact in HTA. As a core member of Cytel’s EU Joint Clinical Assessment (JCA) Taskforce, she participates in diverse EU JCA-related projects, mainly focusing on the JCA scoping process. She leads EU JCA PICO simulations and Market Access strategy projects, including assessments of evidence generation plans, clinical development plans, and target product profiles from the HTA and payers’ perspective mostly across European markets.
